175 related articles for article (PubMed ID: 86771)
1. Oestrogen receptors and prognosis in early breast cancer.
Cooke T; George D; Shields R; Maynard P; Griffiths K
Lancet; 1979 May; 1(8124):995-7. PubMed ID: 86771
[TBL] [Abstract][Full Text] [Related]
2. Possible test for selection of adjuvant systemic therapy in early cancer of the breast.
Cooke T; George WD; Griffiths K
Br J Surg; 1980 Oct; 67(10):747-50. PubMed ID: 7427030
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen receptors and primary breast cancer.
Humeniuk V; Hawkins RA; Prescott RJ; Roberts MM; Stewart HJ; Forrest AP
Aust N Z J Surg; 1982 Aug; 52(4):408-14. PubMed ID: 6956318
[TBL] [Abstract][Full Text] [Related]
4. [Relation of steroid hormone receptors to axillary lymph node metastasis in breast carcinoma].
Etzrodt A; Jung H; Schweissfurth C; Tolxdorff T; Lamberti G
Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):726-31. PubMed ID: 6559147
[TBL] [Abstract][Full Text] [Related]
5. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.
Howat JM; Harris M; Swindell R; Barnes DM
Br J Cancer; 1985 Feb; 51(2):263-70. PubMed ID: 3966982
[TBL] [Abstract][Full Text] [Related]
6. Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.
Maynard PV; Davies CJ; Blamey RW; Elston CW; Johnson J; Griffiths K
Br J Cancer; 1978 Dec; 38(6):745-8. PubMed ID: 743491
[TBL] [Abstract][Full Text] [Related]
7. Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis.
Leake RE; Laing L; McArdle C; Smith DC
Br J Cancer; 1981 Jan; 43(1):67-71. PubMed ID: 7459240
[TBL] [Abstract][Full Text] [Related]
8. Early recurrence in breast cancer with efferent vascular invasion: a preliminary report.
Hartveit F; Støa KF; Tangen M
Invest Cell Pathol; 1980; 3(2):141-5. PubMed ID: 7380665
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen receptors and survival in early breast cancer.
Croton R; Cooke T; Holt S; George WD; Nicolson R; Griffiths K
Br Med J (Clin Res Ed); 1981 Nov; 283(6302):1289-91. PubMed ID: 6794823
[TBL] [Abstract][Full Text] [Related]
10. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of estrogen receptors in breast cancer (author's transl)].
Reiner G; Jakesz R; Kolb R; Bettelheim P; Bieglmayer C; Spona J
Chir Forum Exp Klin Forsch; 1980; ():315-8. PubMed ID: 7389473
[TBL] [Abstract][Full Text] [Related]
12. Tumour cellularity, oestrogen receptors and prognosis in breast cancer.
Black R; Prescott R; Bers K; Hawkins A; Stewart H; Forrest P
Clin Oncol; 1983 Dec; 9(4):311-8. PubMed ID: 6661854
[TBL] [Abstract][Full Text] [Related]
13. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
14. The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution.
Cherubini M; Baxa P; Guarino G
Chir Ital; 2002; 54(4):423-8. PubMed ID: 12239750
[TBL] [Abstract][Full Text] [Related]
15. Polyamines in breast cancer.
Kingsnorth AN; Wallace HM; Bundred NJ; Dixon JM
Br J Surg; 1984 May; 71(5):352-6. PubMed ID: 6722462
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients.
Crowe JP; Hubay CA; Pearson OH; Marshall JS; Rosenblatt J; Mansour EG; Hermann RE; Jones JC; Flynn WJ; McGuire WL
Breast Cancer Res Treat; 1982; 2(2):171-6. PubMed ID: 7171837
[TBL] [Abstract][Full Text] [Related]
17. The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast.
Winstanley J; Cooke T; George WD; Murray G; Holt S; Croton R; Griffiths K; Nicholson R
Br J Cancer; 1991 Jul; 64(1):99-101. PubMed ID: 1854633
[TBL] [Abstract][Full Text] [Related]
18. Steroid-hormone receptors and survival after first relapse in breast cancer.
Howell A; Barnes DM; Harland RN; Redford J; Bramwell VH; Wilkinson MJ; Swindell R; Crowther D; Sellwood RA
Lancet; 1984 Mar; 1(8377):588-91. PubMed ID: 6142305
[TBL] [Abstract][Full Text] [Related]
19. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
Fisher B; Jeong JH; Bryant J; Anderson S; Dignam J; Fisher ER; Wolmark N;
Lancet; 2004 Sep 4-10; 364(9437):858-68. PubMed ID: 15351193
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen-receptor status and sites of metastasis in breast cancer.
Campbell FC; Blamey RW; Elston CW; Nicholson RI; Griffiths K; Haybittle JL
Br J Cancer; 1981 Sep; 44(3):456-9. PubMed ID: 7284240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
